NAFLD is associated with systemic inflammatory responses characterized by elevated circulating levels of tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and CC-chemokine ligand 2 (CCL2) [15]. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.